Care este prețul pentru Abivax S.A. (ABVX)

Prețul pentru Abivax S.A. (ABVX) este $121.34

Care este capitalizarea de piață pentru Abivax S.A. (ABVX)

Capitalizarea de piață pentru Abivax S.A. (ABVX) este $10.58B

Abivax S.A. (ABVX) Dividende

Abivax S.A. is a Paris-based pharmaceutical firm, established in 2013, dedicated to identifying and refining treatments for various serious conditions, including inflammatory and infectious diseases, as well as cancer. Its primary drug candidate, ABX464, is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's disease, and COVID-19, and is in Phase IIa trials for rheumatoid arthritis. This compound has also successfully completed a Phase IIa study focused on achieving viral remission in HIV patients. Additionally, the company is advancing ABX 196, an immune-enhancing agent, through Phase 1/2 clinical trials for hepatocellular cancer. Beyond these main programs, Abivax is also engaged in research initiatives targeting Dengue fever, influenza, and the respiratory syncytial virus. The company holds significant licensing agreements with esteemed institutions such as the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie.

An	Dividend (ajustat pentru split de acțiuni)	Schimbă
Nu sunt suficiente date pentru perioada selectată.

Dividend (ajustat pentru split de acțiuni)

Schimbă

Nu sunt suficiente date pentru perioada selectată.

An	Dividend	Schimbă
Nu sunt suficiente date pentru perioada selectată.

Dividend

Schimbă

Nu sunt suficiente date pentru perioada selectată.

Companie	Număr de plăți de dividende	Țara
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Moderna, Inc. MRNA.US	0.00%	US
CSL Limited CSL.AX	64.00%	AU
Lonza Group AG LONN.SW	0.00%	CH

Companie

Număr de plăți de dividende

Țara